What is STASON PHARMACEUTICALS?
STASON PHARMACEUTICALS is a US-based global pharmaceutical entity with a specialized focus on oncology, renal, and orphan indications. The company offers comprehensive contract manufacturing, analytical testing, and CDMO services, catering to drug-development firms with capabilities for high potency product production. STASON PHARMACEUTICALS has also diversified into consumer supplement products and operates advanced high containment facilities for handling potent compounds. Leveraging over 26 years of industry experience, the company maintains a strong foothold in the generic market and cultivates a worldwide network of distributors, positioning itself as a key player in pharmaceutical development and manufacturing.
How much funding has STASON PHARMACEUTICALS raised?
STASON PHARMACEUTICALS has raised a total of $931K across 2 funding rounds:
Debt
$350K
Debt
$581K
Debt (2020): $350K with participation from PPP
Debt (2021): $581K led by PPP
Key Investors in STASON PHARMACEUTICALS
PPP
Public-Private Partnership
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for STASON PHARMACEUTICALS?
The substantial enterprise-level funding and recent strategic investment signal a period of accelerated growth and potential market expansion for STASON PHARMACEUTICALS. This capital infusion is likely to fuel further research and development in their specialized therapeutic areas, enhance manufacturing capacities, and potentially broaden their global distribution network. The company's established expertise in contract manufacturing and CDMO services, coupled with its expansion into consumer supplements, suggests a multi-faceted strategy aimed at maximizing market opportunities and solidifying its position as a comprehensive pharmaceutical solutions provider.
See full STASON PHARMACEUTICALS company page
